Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLG)

Last Price

1.82

Today's Change

-0.05 (2.67%)

Day's Change

1.82 - 1.90

Trading Volume

45,947

Overview

Market Cap

3 Million

Shares Outstanding

2 Million

Avg Volume

4,963,673

Avg Price (50 Days)

1.71

Avg Price (200 Days)

2.20

PE Ratio

-0.11

EPS

-17.24

Earnings Announcement

12-Nov-2024

Previous Close

1.87

Open

1.84

Day's Range

1.8201 - 1.8999

Year Range

0.8 - 10.56

Trading Volume

53,577

Price Change Highlight

1 Day Change

-2.67%

5 Day Change

22.98%

1 Month Change

52.95%

3 Month Change

49.19%

6 Month Change

2.25%

Ytd Change

-56.04%

1 Year Change

-60.77%

3 Year Change

-99.85%

5 Year Change

-99.94%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment